Jan 10, 2025 11:30AM
Jan 10, 2025 11:30AM
Nov 14, 2024 04:15PM
Nov 13, 2024 07:01AM
Nov 13, 2024 07:00AM
Oct 31, 2024 07:31AM
Oct 31, 2024 07:30AM Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma
Sep 23, 2024 07:30AM
Aug 14, 2024 06:05PM
May 15, 2024 05:13PM
May 1, 2024 08:31AM
May 1, 2024 08:30AM
Apr 18, 2024 07:02AM
Apr 15, 2024 05:20PM Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Mar 12, 2024 08:00AM
Mar 12, 2024 08:00AM
Feb 15, 2024 04:05PM
Oct 31, 2023 12:33PM
Oct 31, 2023 12:30PM
Sep 30, 2022 08:41AM
Sep 30, 2022 08:41AM Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage at the European Socie
Aug 15, 2022 04:15PM
Aug 15, 2022 04:15PM
Aug 1, 2022 07:52AM
Aug 1, 2022 07:51AM
Aug 1, 2022 07:51AM
Jun 29, 2022 06:34AM
Jun 29, 2022 06:30AM Aileron Therapeutics Announces Interim Data from Phase 1b Chemoprotection Trial of ALRN-6924 in Patients with p53-Mutated Non-Small Cell Lung Cancer (NSCLC) and Confirms Development Path for ALRN-6924
Jun 29, 2022 06:30AM
Mar 24, 2021 04:36PM
Mar 2, 2021 07:14AM
Mar 2, 2021 07:00AM
Mar 2, 2021 07:00AM
Nov 7, 2019 07:30AM
Aug 6, 2019 04:10PM Aileron Therapeutics Reports Second Quarter 2019 Financial Results
Jun 27, 2019 08:05AM
Jun 27, 2019 08:00AM
Aug 7, 2018 04:15PM
Aug 7, 2018 04:15PM
Mar 28, 2018 07:00AM
Mar 28, 2018 07:00AM
Nov 9, 2017 04:18PM Aileron Therapeutics Reports Third Quarter 2017 Financial Results
Aug 10, 2017 04:11PM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All